Daiichi Sankyo (India)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (India), India, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
66%
Total
Publications
307
Total Open
Publications
202
Total
Citations
6.3K
Open Access
Percentage
66%
Total
Publications
307
Total Open
Publications
202
Total
Citations
6.3K
Breakdown
Publisher Open
54%
Both
8%
Other Platform Open
4%
Closed
34%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 9%
17
Hybrid 14%
27
No Guarantees 77%
145
Other Platform Open
Domain 78%
29
Institution 16%
6
Public 16%
6
Preprint 8%
3
Other Internet 8%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 29 |
Europe PMC | Domain | 22 |
Semantic Scholar | Public | 6 |
bioRxiv | Preprint | 3 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
Aalborg Universitet - VBN Forskningsportal | Other Internet | 2 |
University of Warwick - Warwick Research Archive Portal | Institution | 1 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 1 |
University of Hull - Repository@Hull (Worktribe) | Institution | 1 |